Showing 101-120 of 374 for: Cochrane Systematic Reviews > Oncology 
- Dietary flavonoid for preventing colorectal neoplasms
Cochrane Systematic Reviews, 25-Jun-2012
Flavonoids are polyphenolic compounds that are distributed widely in the plant kingdom; they are especially abundant in fruits and vegetables. More than 5,000 individual flavonoids have been identified and classified into more than 10 subgroups according
- Different anthracycline derivates for reducing cardiotoxicity in cancer patients
Cochrane Systematic Reviews, 24-Feb-2015
The use of anthracyclines is limited by the occurrence of cardiotoxicity. In an effort to prevent this cardiotoxicity, different anthracycline derivates have been studied.
- Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy
Cochrane Systematic Reviews, 3-Mar-2016
This review update has been managed by both the Childhood Cancer and Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Groups.
- Doxorubicin‐based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma
Cochrane Systematic Reviews, 21-Jul-2003
Considerable controversy exists as to whether any benefit of doxorubicin-based combination chemotherapy outweighs increased toxic effects, inconvenience, and additional costs, compared to single-agent doxorubicin. There is substantial variation in clinica
- Drug therapy for the management of cancer-related fatigue
Cochrane Systematic Reviews, 1-Aug-2010
This review is an update of a previously published review in The Cochrane Database of Systematic Reviews (Issue 1 2008). Cancer-related fatigue (CRF) is common, under-recognised and difficult to treat. There have been studies looking at drug interventions
- Drugs for preventing lung cancer in healthy people
Cochrane Systematic Reviews, 6-Sep-2012
This is an updated version of the original review published in Issue 2, 2003. Some studies have suggested a protective effect of antioxidant nutrients on lung cancer. Observational epidemiological studies suggest an association between higher dietary leve
- Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer
Cochrane Systematic Reviews, 11-Jun-2019
Standard androgen suppression therapy (AST) using surgical or medical castration is considered a mainstay of advanced hormone-sensitive prostate cancer treatment. AST can be initiated early when disease is asymptomatic or deferred when patients suffer sym
- Early versus deferred treatment for early stage multiple myeloma
Cochrane Systematic Reviews, 13-Mar-2012
Early stage multiple myeloma (MM) represents about 20% of MM. Most of the patients are asymptomatic. Thus, it is far less dramatic than advanced disease and may require different treatment strategies. For these patients, it is not clear whether it is bett
- Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer
Cochrane Systematic Reviews, 8-Nov-2010
This is an update of the original review published in Issue 1, 2005. It is standard clinical practice to combine chemotherapy and chest radiotherapy in treating patients with limited-stage small cell lung cancer. However, the best way to integrate both mo
- Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia
Cochrane Systematic Reviews, 9-Apr-2015
Cancer cachexia is a distressing weight loss syndrome commonly seen in advanced cancer patients. It is associated with reduced quality of life and shorter survival time. Eicosapentaenoic acid (EPA) is a long chain polyunsaturated fatty acid found naturall
- Elemene for the treatment of lung cancer
Cochrane Systematic Reviews, 8-Mar-2012
Elemene, isolated from the Chinese medicinal herb Rhizoma Zedoariae and be used to treat patients with lung cancer in China. Until now, the effects have not been systematically reviewed.
- Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer
Cochrane Systematic Reviews, 11-Feb-2015
The pattern of infections among neutropenic cancer patients has shifted in the last decades to a predominance of Gram-positive infections. Some of these Gram-positive bacteria are increasingly resistant to beta-lactams and necessitate specific antibiotic
- Endoscopic mucosal resection for early gastric cancer
Cochrane Systematic Reviews, 1-Oct-2014
The treatment of early gastric cancer (EGC) using endoscopy, namely endoscopic mucosal resection (EMR), has been adopted for about 20 years, but the effectiveness and safety of the modality are still controversial. Furthermore, the risk of bias of trials
- Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgery
Cochrane Systematic Reviews, 10-Nov-2008
Postoperative morbidity and mortality are high in patients undergoing pancreatico-duodenectomy for malignant pancreatico-biliary stricture. Different approaches have been tried to improve the outcomes, including pre-surgical biliary stenting with endoscop
- Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy
Cochrane Systematic Reviews, 7-Dec-2012
This is an update of a Cochrane review first published in The Cochrane Library in Issue 3, 2010.
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
Cochrane Systematic Reviews, 15-Oct-2018
This is an update of a previously published version of the review (Issue 10, 2011).
- Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Cochrane Systematic Reviews, 12-May-2009
Tumour hypoxia increases tumour invasiveness and has a negative impact on response to therapy. Hypoxic tumours are also associated with severely anaemic individuals. It has therefore been hypothesised that correcting anaemia, by increasing haemoglobin lev
- Erythropoietin or darbepoetin for patients with cancer
Cochrane Systematic Reviews, 5-Nov-2012
Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions.
- Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data
Cochrane Systematic Reviews, 29-Sep-2010
Erythropoiesis-stimulating agents (ESAs) reduce anemia in cancer patients and may improve quality of life, but there are concerns that ESAs might increase mortality.
- Evaluation of follow‐up strategies for patients with epithelial ovarian cancer following completion of primary treatment
Cochrane Systematic Reviews, 8-Sep-2014
Ovarian cancer is the sixth most common cancer and seventh commonest cause of death in women worldwide. Traditionally, many people who have been treated for cancer undergo long-term follow-up in secondary care. However, it has been suggested that the use
